PKC alpha CLIA Kit

Produktnummer ABIN6206699

Produktdetails PKC alpha CLIA Kit

Target: PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))

Reaktivität: Maus

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.781 ng/mL - 50 ng/mL

Untere Nachweisgrenze: 0.781 ng/mL

Applikation: ELISA

Verwendungszweck: Mouse Protein Kinase C alpha (PKCa) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates and other biological fluids.

Proben: Tissue Homogenate

Analytische Methode: Quantitative

Sensitivität: < 0.31 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))

Andere Bezeichnung: Protein Kinase C alpha (PKCa) (PKCa Produkte)

Synonyme: pkc-alpha CLIA Kit, pkcalpha CLIA Kit, im:7139045 CLIA Kit, si:dkey-8l19.1 CLIA Kit, LOC100219195 CLIA Kit, AAG6 CLIA Kit, PKC-alpha CLIA Kit, PKCA CLIA Kit, PRKACA CLIA Kit, AI875142 CLIA Kit, Pkca CLIA Kit, PKRCA CLIA Kit, protein kinase C alpha CLIA Kit, protein kinase C, alpha L homeolog CLIA Kit, protein kinase C, alpha CLIA Kit, PRKCA CLIA Kit, prkca.L CLIA Kit, prkca CLIA Kit, Prkca CLIA Kit

Pathways: WNT Signalweg, T-Zell Rezeptor Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling